Sc. Kirkwood et al., Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers, ARCH NEUROL, 56(5), 1999, pp. 563-568
Objective: To determine whether longitudinal changes in cognitive and motor
function can be detected among clinically presymptomatic individuals carry
ing the Huntington disease (HD) allele.
Design: A longitudinal, case-control, double-blind study comparing presympt
omatic gene carriers and non-gene carriers at risk for HD examined an avera
ge of 3.7 years apart.
Setting: The Department of Medical and Molecular Genetics at a general clin
ic research center in Indianapolis, Ind.
Participants: A sample of 43 at-risk individuals consisting of presymptomat
ic gene carriers (n = 12) and non-gene carriers (n = 31).
Measures: Huntington disease gene status was determined by molecular testin
g of the HD gene. Subscales from the Wechsler Adult Intelligence Scale-Revi
sed and a quantified neurologic rating scale were administered.
Results: Scores on the digit symbol subscale of the Wechsler Adult Intellig
ence Scale-Revised (P < .05) and 2 neurologic variables-optokinetic nystagm
us (P < .01) and rapid alternating movements (P < .005)-declined more rapid
ly among presymptomatic gene carriers than among non-gene carriers. At foll
ow-up examination, compared with non-gene carriers, presymptomatic gene car
riers had significantly lower scores on the digit symbol subscale (P = .02)
and for 4 neurologic variables-rapid alternating movements (P < .005), opt
okinetic nystagmus (P < .001), overall ocular movements (P < .02), and chor
ea of the trunk (P < .02).
Conclusions: Psychomotor speed, optokinetic nystagmus, and rapid alternatin
g movements demonstrated significant decline early in the pathological proc
ess of HD. These results suggest that subtle worsening of psychomotor, ocul
omotor, and motor functions occurs before the onset of signs sufficient to
make a clinical diagnosis in individuals who have inherited the HD allele.